Cajal Neuroscience
Seattle
About Cajal Neuroscience
Cajal Neuroscience is a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration. The company combines a suite of state-of-the-art approaches and technologies, including integrative human genetics and multi-omics, high-throughput functional genomics, and advanced microscopy, to accelerate neurodegeneration target and drug discovery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $96.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: cajalneuro.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Neuroscience, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cajal-neuroscience-78204 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.